Please provide your email address to receive an email when new articles are posted on . Across three measures of oxygen utilization, researchers observed improvement with pegtarazimod vs. placebo.

Rationale In patients with COVID-19 pneumonia and mild hypoxaemia, the clinical benefit of high-flow nasal oxygen (HFNO) remains unclear. We aimed to examine whether HFNO compared with conventional ...

Correspondence to Professor Siew C Ng, Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong; siewchienng{at}cuhk.edu.hk Objective Although COVID-19 is primarily a ...

Douglas Kondo, MD, Associate Professor (Clinical), is an adult and child psychiatrist, and brain imaging researcher who works at the Salt Lake City VA Healthcare ...

Introduction Supplemental oxygen is commonly used in trauma patients, although it may lead to hyperoxaemia that has been associated with pulmonary complications and increased mortality. The primary ...

Background Early warning systems (EWS) used across the world typically assign a fixed number of points to patients receiving supplemental oxygen, regardless of amount. This ordinal binary approach may ...

Cancer Prevention and Treatment Center, Department of Thoracic Surgery, Sun Yat-sen University, Guangzhou, China. Lung cancer refers to the tumor that occurs in the bronchial mucosal epithelium, also ...

The innate immune response plays an important role in the pathophysiology of acute respiratory distress syndrome (ARDS); however, no drug has been proven to be beneficial in the management of ARDS.

Objective To examine whether supraphysiological oxygen administration during surgery is associated with lower or higher postoperative kidney, heart, and lung injury. Design Observational cohort study.

Acute respiratory distress syndrome (ARDS) is commonly seen in patients with acute brain injury (ABI), with prevalence being as high as 35%. These patients often have additional risk factors for ARDS ...